Manuel Campos Toimil

Manuel Campos Toimil is a Professor at the University of Santiago de Compostela, affiliated with the Faculty of Pharmacy and the Department of Pharmacology, Pharmacy and Pharmaceutical Technology. He leads the research group FIFAEC (Physiology and Pharmacology of Chronic Diseases) within the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). A Doctor of Pharmacy from USC since 1995, his thesis explored hydralazine’s cardiovascular effects under Dr. Francisco Orallo Cambeiro.

Research Interests: His work focuses on pharmacological mechanisms of chronic diseases, particularly cardiovascular pathophysiology, drug-induced effects on endothelial function, nitric oxide signaling, and metabolic disorders. He investigates novel therapies for hypertension, diabetes, and inflammatory conditions using in vivo models and molecular techniques. Key areas include SGLT2 inhibitors, probiotics (kefir), and natural compounds like resveratrol and curcumin.

Publications: Recent studies highlight vascular aging mechanisms, lipid metabolism in heart failure, and anti-inflammatory actions of sodium nitroprusside. His work bridges pharmacology and clinical practice, addressing drug interactions (e.g., voriconazole-PPI effects) and optimizing therapies for Crohn’s disease and heart failure.

Awards & Grants: No explicit awards noted, but his research is supported by collaborations with CIMUS and multidisciplinary teams. His lab focuses on translational research linking molecular mechanisms to clinical outcomes in chronic diseases.

Labs & Teams: Principal investigator at CIMUS, collaborating across disciplines in pharmacology, cardiology, and microbiome research. Active in mentoring early-career researchers through thesis supervision and grant proposals.